Cancer Research and Treatment

Navigating patient journey in early diagnosis of lung cancer in India

Bivas Biswas, Deepak Talwar, Priti Meshram, PramodK Julka, Anurag Mehta, SP Somashekhar, Srinivas Chilukuri, Abhishek Bansal

Design, Synthesis and Anticancer Evaluation of Nitroimidazole Radiosensitisers

Lydia P. Liew, Avik Shome, Way W. Wong, Cho R. Hong, Kevin O. Hicks, Stephen M. F. Jamieson, Michael P. Hay

Breast Metastasis of Lung Cancer After Computed Tomography-Guided Core Needle Biopsy: A Case Report

Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent

Michela Buglione, Barbara Alicja Jereczek-Fossa, Marco Lorenzo Bonù, Davide Franceschini, Andrei Fodor, Isa Bossi Zanetti, Marianna Alessandra Gerardi, Paolo Borghetti, Davide Tomasini, Nadia Gisella Di Muzio, Olga Oneta, Marta Scorsetti, Ciro Franzese, P

Girish S. Shroff, Chitra Viswanathan, Brett W. Carter, Marcelo F. Benveniste, Mylene T. Truong, Bradley S. Sabloff

Radiologic Clinics of North America.2018; 56(3): 411. CrossRef

Stereotactic Body Radiation Therapy for Early-Stage Non–Small Cell Lung Cancer: A Primer for Radiologists

Jennifer A. Febbo, Ramya S. Gaddikeri, Palmi N. Shah

Preliminary comparison of the registration effect of 4D-CBCT and 3D-CBCT in image-guided radiotherapy of Stage IA non–small-cell lung cancer

Journal of Radiation Research.2017; 58(6): 854. CrossRef

The Journal of Thoracic and Cardiovascular Surgery.2016; 152(2): 338. CrossRef

Efficacy of stereotactic radiotherapy for brain metastases using dynamic jaws technology in the helical tomotherapy system

Taro Murai, Akihiro Hayashi, Yoshihiko Manabe, Chikao Sugie, Taiki Takaoka, Takeshi Yanagi, Tetsuya Oguri, Masayuki Matsuo, Yoshimasa Mori, Yuta Shibamoto

The British Journal of Radiology.2016; 89(1066): 20160374. CrossRef

Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium

Erik O. Pettersen, Peter Ebbesen, Roben G. Gieling, Kaye J. Williams, Ludwig Dubois, Philippe Lambin, Carol Ward, James Meehan, Ian H. Kunkler, Simon P. Langdon, Anne H. Ree, Kjersti Flatmark, Heidi Lyng, Maria J. Calzada, Luis del Peso, Manuel O. Landazu

Journal of Enzyme Inhibition and Medicinal Chemistry.2015; 30(5): 689. CrossRef

Monte Carlo validation of the TrueBeam 10XFFF phase–space files for applications in lung SABR

Tony Teke, Cheryl Duzenli, Alanah Bergman, Francis Viel, Parmveer Atwal, Ermias Gete

Stratégies d’évaluation de la réponse après irradiation stéréotaxique des cancers bronchiques primitifs et des métastases pulmonaires

Short-Course Treatment With Gefitinib Enhances Curative Potential of Radiation Therapy in a Mouse Model of Human Non-Small Cell Lung Cancer

Sivan M. Bokobza, Yanyan Jiang, Anika M. Weber, Aoife M. Devery, Anderson J. Ryan

International Journal of Radiation Oncology*Biology*Physics.2014; 88(4): 947. CrossRef

Can an alternative backround-corrected [18F] fluorodeoxyglucose (FDG) standard uptake value (SUV) be used for monitoring tumor local control following lung cancer stereotactic body radiosurgery?

Charles Shang, Michael Kasper, Vindu Kathriarachchi, Rashmi Benda, Joseph Kleinman, Jeremy Cole, Timothy Williams

International Journal of Cancer Therapy and Oncology.2014; 2(3): 020317. CrossRef

Stereotactic ablative body radiotherapy combined with immunotherapy: Present status and future perspectives

N.H. Rekers, E.G.C. Troost, C.M.L. Zegers, W.T.V. Germeraad, L.J. Dubois, P. Lambin

Cancer/Radiothérapie.2014; 18(5-6): 391. CrossRef

Medicine - Programa de Formación Médica Continuada Acreditado.2014; 11(67): 3983. CrossRef

Increasing Use of Advanced Radiation Therapy Technologies in the Last 30 Days of Life Among Patients Dying As a Result of Cancer in the United States

B. Ashleigh Guadagnolo, Kai-Ping Liao, Sharon H. Giordano, Linda S. Elting, Thomas A. Buchholz, Ya-Chen Tina Shih

Journal of Oncology Practice.2014; 10(4): e269. CrossRef

Extra-thoracic tumor burden but not thoracic tumor burden on 18F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer

Jong-Ryool Oh, Ji-Hyoung Seo, Chae Moon Hong, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee, Jung-Joon Min, Ho-Chun Song, Hee-Seung Bom, Young-Chul Kim, Byeong-Cheol Ahn

Changing trends in radiation therapy technologies in the last year of life for patients diagnosed with metastatic cancer in the United States

B. Ashleigh Guadagnolo, Jinhai Huo, Kai‐Ping Liao, Thomas A. Buchholz, Prajnan Das

Escaping death to quiescence: Avoiding mitotic catastrophe after DNA damage

CyberKnife robotic image-guided stereotactic radiotherapy for oligometastic cancer

B.A. Jereczek-Fossa, I. Bossi-Zanetti, R. Mauro, G. Beltramo, L. Fariselli, L.C. Bianchi, C. Fodor, P. Fossati, G. Baroni, R. Orecchia

Strahlentherapie und Onkologie.2013; 189(6): 448. CrossRef

The development of stereotactic body radiotherapy (SBRT) for medically inoperable early stage non-small cell lung cancer: an international phenomenon

Journal of Radiation Oncology.2012; 1(1): 3. CrossRef

Improving lung cancer survival; time to move on

Marlies E Heuvers, Joost P Hegmans, Bruno H Stricker, Joachim G Aerts

Radiographic changes after lung stereotactic ablative radiotherapy (SABR) – Can we distinguish recurrence from fibrosis? A systematic review of the literature

Kitty Huang, Max Dahele, Suresh Senan, Matthias Guckenberger, George B. Rodrigues, Aaron Ward, R. Gabriel Boldt, David A. Palma

Radiotherapy and Oncology.2012; 102(3): 335. CrossRef